USPTO serial 79273535
YUHYLYX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 10, 2020
- Examiner
- JOHNSON, BRITTANY S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with YUHYLYX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard Y. Kim
Richard Y. Kim Snell & Wilmer L.L.P.400 East Van Buren Street, Suite 1900One Arizona CenterPhoenix, AZ 85004-2202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Androgen preparations; pharmaceutical agents affecting metabolism; pharmaceutical preparations for treatment of erectile dysfunction and benign prostate hyperplasia; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for inducing erections; pharmaceutical preparations for treatment of conditions affecting urogenital organs; pharmaceutical preparations for prevention of sexual dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treatment of benign prostate hyperplasia; drugs for medical purposes, pharmaceutical drugs and medicines for human purposes, namely, pharmaceutical preparations for the treatment and prevention of ophthalmic, dermatological, urological, hematological, bone, skeletal, respiratory, endocrinological, circulatory, gastroenterological, hormonal, diabetic, muscular, rheumatic, immune system, ocular, psychiatric, cognitive, mood, infectious, oncological, gynecological, sexual, and pediatric disorders; hormones for medical purposes; pharmaceutical drugs in the nature of pharmaceutical preparations used for the treatment of Alopecia, Androgenetic Alopecia, and Alopecia Areata; pharmaceutical preparations for treatment of premature ejaculation; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for treatment of conditions affecting respiratory organs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 14, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 24, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 23, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 10, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 10, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 25, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 25, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 22, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 22, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 22, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 28, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 10, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 10, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 18, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 14, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |